Skip to main content
Premium Trial:

Request an Annual Quote

IBM to Make Processing Time Available for Blue Gene

NEW YORK, March 11 (GenomeWeb News) - IBM plans to make processing time on its Blue Gene supercomputer available to customers on demand, the company said today.


Essentially, IBM will allow customers to have remote access to the powerful supercomputing system through a secure virtual private network and pay only for the amount of capacity reserved.


The company said it expects this new program to expand its user-base to those who previously might not have been able to access supercomputers because of the cost.


The supercomputer dedicated to this is located at IBM's Rochester, Minn., facility.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.